Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s40256-020-00406-0

http://scihub22266oqcxt.onion/10.1007/s40256-020-00406-0
suck pdf from google scholar
32281055!7152511!32281055
unlimited free pdf from europmc32281055    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32281055      Am+J+Cardiovasc+Drugs 2020 ; 20 (3): 217-221
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19 #MMPMID32281055
  • Kow CS; Zaidi STR; Hasan SS
  • Am J Cardiovasc Drugs 2020[Jun]; 20 (3): 217-221 PMID32281055show ga
  • There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.
  • |*Betacoronavirus/drug effects/physiology[MESH]
  • |*Cardiovascular Diseases/drug therapy/epidemiology/metabolism[MESH]
  • |*Pandemics[MESH]
  • |Angiotensin II Type 1 Receptor Blockers/*pharmacology[MESH]
  • |Angiotensin-Converting Enzyme Inhibitors/*pharmacology[MESH]
  • |Antihypertensive Agents/pharmacology[MESH]
  • |COVID-19[MESH]
  • |Comorbidity[MESH]
  • |Confounding Factors, Epidemiologic[MESH]
  • |Coronavirus Infections/diagnosis/epidemiology/metabolism[MESH]
  • |Global Health[MESH]
  • |Humans[MESH]
  • |Pneumonia, Viral/diagnosis/epidemiology/metabolism[MESH]
  • |Renin-Angiotensin System/*drug effects[MESH]
  • |Risk Assessment[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box